LeBlanc P P, Back N
J Natl Cancer Inst. 1975 May;54(5):1107-4. doi: 10.1093/jnci/54.5.1107.
Ascitic fluid and ascites tumor cells from Swiss mice bearing Ehrlich ascites tumor were assayed for components of the kallikrein-kinin system at various times during tumor growth. Changes in component levels were correlated with those in the plasma. Ascitic fluid contained an acetone-activated prekallikrein that increased in concentration during tumor growth and reached peak levels during the 7th-10th day post transplant. No free kinin activity was present in the ascitic fluid. During tumor growth, kininogen levels increased in parallel with prekallikrein levels. The ascitic fluid also contained a kinin-destroying activity that was initially high during the early phase of tumor growth. Tumor cell fractions, prepared by ultracentrifugal techniques, had no kinin-forming activity while possessing kinin-destroying activity that was localized in the soluble protoplasmic protein and nuclear fractions. The kinin-forming activity of the ascitic fluid resembled that of the plasma with respect to pH optima, kinetics of kinin formation, and effect of protease inhibitors. The kininase activity of both ascitic fluid and plasma differed from that of the tumor cell fractions.
对携带艾氏腹水瘤的瑞士小鼠的腹水和腹水肿瘤细胞在肿瘤生长的不同时期进行激肽释放酶-激肽系统成分分析。成分水平的变化与血浆中的变化相关。腹水中含有一种丙酮激活的前激肽释放酶,其浓度在肿瘤生长过程中增加,并在移植后第7 - 10天达到峰值水平。腹水中不存在游离激肽活性。在肿瘤生长过程中,激肽原水平与前激肽释放酶水平平行增加。腹水还含有一种激肽破坏活性,在肿瘤生长早期最初较高。通过超速离心技术制备的肿瘤细胞组分没有激肽形成活性,而具有定位于可溶性原生质蛋白和核组分中的激肽破坏活性。腹水的激肽形成活性在最适pH、激肽形成动力学和蛋白酶抑制剂的作用方面类似于血浆。腹水和血浆的激肽酶活性与肿瘤细胞组分的不同。